Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
Bone Biologics Corp entered into Securities Purchase Agreement with certain institutional investors valued at Combined offering price of $2.56 per Share and accompanying Warrant and $2.559 per Pre-Funded Warran (effective 2024-03-04).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- certain institutional investors
- Value
- Combined offering price of $2.56 per Share and accompanying Warrant and $2.559 per Pre-Funded Warran
- Effective
- 2024-03-04
Exact text from the filing
On March 4, 2024, Bone Biologics Corporation (the “Company”) priced a public offering (the “Offering”) of (i) 119,000 shares (the “Shares”) of its common stock, par value $0.001 per share (the “Common Stock”), together with warrants (the “Warrants”) to purchase 119,000 shares of Common Stock at a combined public offering price of $2.56 per Share and accompanying Warrant and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase 662,251 shares of Common Stock, together with Warrants to purchase 662,251 shares of Common Stock at a combined public offering price of $2.559 per Pre-Funded Warrant and accompanying Warrant.
View on SEC.gov